Preventing SRSF3 degradation by inhibiting neddylation prevented NAFLD progression in mice, consistent with the fact that the inhibition of neddylation pathway was shown to reverse liver fibrosis in vivo (67). This evidence concerns the gene SRSF3 and metabolic dysfunction-associated steatotic liver disease.